Springer Nature, London, 2022. 6p.
COVID-19 saw disruptions and adaptations to the provision of harm reduction services. It is possible that SDMs filled the gap - this paper explores changes to harm reduction usage during lockdowns.
Burnet Institute and Kirby Institute, Melbourne, 2022. 90p.
Monitors trends in data from measurement of new infections, counts of people tested and treated, and people receiving hepatitis C related liver transplants, through to projections based on mathematical modelling.
MDPI, Basel, 2022. 11p.
This approach incudes the ID and validation of samples that are inactivated and stable at ambient temperature and the development of a smart phone-enabled portal for data entry and analyses.
Hepatitis NSW, Sydney, 2022. Video 4:03 minutes
Shot at a drop-in centre for people experiencing, or at risk of, homelessness, 2 peers talk about their work helping facilitate testing and treatment for people who often face barriers accessing health care.
Aust Federation of AIDS Organisations, Anwernekenhe National HIV Alliance, Sydney, 2022. Webpage.
How to receive free and confidential reminders (either as an email or SMS) to go for a sexual health check-up. Part of the ‘Better to Know’ resource for Aboriginal and Torres Strait Islander people.
National Institute of Allergy and Infectious Diseases, Bethesda, 2022. 3p.
People living with HIV are at greater risk of liver-related illness and death when co-infected with HBV. A 3 dose course of a hep B vaccine fully protected adults living with HIV who had never been vaccinated against or infected with HBV.
MDPI, Basel, 2022. 8p.
HCV infections among MSM in the Netherlands and Belgium are clustered and highly suitable for targeted strategies, such as contact tracing and partner notification. But despite HCV reduction after DAA HCV transmission persisted in the same clusters.
US Nat Library of Medicine, Bethesda, 2021. 3p.
Overview of a study of a community-embedded nurse-led model of HCV care (MoC) for those attending alcohol and other drug (AOD) services in Melbourne, Australia.
JHEP Reports (via Elsevier), London, 2022. 9p.
Hep C treatment has benefits beyond cure, including improving quality of life and decreasing injection risk practices. But intrinsic barriers and the high reinfection rates hamper microelimination in this setting.
Treatment Action Group, New York, 2022. 4p.
There are still many preventable AIDS deaths each year, many caused by TB and HCV – 2 prominent HIV coinfections. This panel discusses opportunities for expanding access to care and cures.
Hepatitis Australia, Canberra, 2020. 2p.
People with chronic hepatitis B have higher rates of depression and anxiety than the general population. This article looks at why this happens, and what we can do about it including diagnosis, treatment, getting healthy, meds and finding support.
You Matter, Vancouver, 2022. 2p.
Peers from discuss the ‘TestLinkCall’ Project which, as part of their support, provides a cell phone for social contact and access to hep C treatment and follow up.
ASHM, NAPWHA, SWOP, et al, Canberra, 2022. 2p.
Information for people who are the subject of a Mandatory Testing Order: a new law that gives police and other public service workers in NSW the power to force people to test for HIV and other blood-borne diseases.
UNSW Community, Sydney, 2022. Video 1:00:31
Seminar presented by Chari Cohen, Catherine Freeland, Yasmin Ibrahim, Thomas Tu and facilitated by Carla Treloar for the UNSW Centre for Social Research in Health.
Hepatitis Queensland, Brisbane, 2022. 5:19 min video
The story of Bec’s experience with hep B: since her diagnosis Bec has come to understand there is a lack of understanding about hep B - both from health care providers and Indigenous community.
World Hepatitis Alliance, Geneva, 2022. 14p.
The advocacy program aimed to support WHA members to develop and implement action plans to overcome barriers to diagnosis in their community. The 5 countries featured are Armenia, Bangladesh, Jamaica, Ghana and Indonesia.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.